Ambrisentan retains its pro-autophagic activity on human pulmonary artery endothelial cells exposed to hypoxia in an in vitro model mimicking diabetes

30 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension: pre-clinical Treatment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by